Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459339 · ClinicalTrials.gov registry record · NA
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
A NA study of Barrett Esophagus, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 5
- Study locations
NCT03459339: Active NA study of Barrett Esophagus, sponsored by Massachusetts General Hospital.
NCT03459339 is a NA study of Barrett Esophagus that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 500 participants, below the 3,550-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03459339, a NA study of Barrett Esophagus, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this research is to follow Barrett's Esophagus participants for 3 years using the tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a multi-site clinical study.
Primary Outcome
We will be measuring the size of the area affected by Barrett's.
Conditions Studied
Interventions
- DEVICE Tethered Capsule Endomicroscopy (TCE)
Study Locations (5)
Florida
- Mayo Clinic - Jacksonville - Jacksonville
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester - Rochester
Missouri
- VA Medical Center - Kansas City
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2028-12 |
| Phase | NA |
What the registry record for NCT03459339 still lists
NCT03459339 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,550-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Tethered Capsule Endomicroscopy (TCE) is the first listed.
NCT03459339 lists 5 locations in 5 states (Florida, Massachusetts, Minnesota).
Frequently Asked Questions
What is clinical trial NCT03459339 about?
NCT03459339 is a clinical study titled "Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy". The goal of this research is to follow Barrett's Esophagus participants for 3 years using the tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a multi-site clinical study.
What is the current status of trial NCT03459339?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2017-04-04. Estimated completion is 2028-12.
What conditions does trial NCT03459339 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT03459339?
The interventions under investigation include: Tethered Capsule Endomicroscopy (TCE) (DEVICE).
Who is sponsoring clinical trial NCT03459339?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03459339 being conducted?
This trial has 5 study locations across Florida, Massachusetts, Minnesota, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03459339's enrollment target sits among peer trials
500 13th of 32 higher than 20 of 32 other Barrett Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI